Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 1 hour ago
Valneva to lay off up to 15% of workforce in face of ‘adverse trend‘ in travel vaccines
about 1 hour ago
Valneva is planning to shrink its headcount by up to 15% as...
Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit
about 1 hour ago
Medtronic will shutter its Santa Rosa facility that produces coronary stents and...
Takeda 0 for 4 against nausea and vomiting after axing another asset
about 4 hours ago
Takeda has ended development of its nausea and vomiting drug candidate for...
AstraZeneca pens agentic AI licensing deal with Owkin
about 7 hours ago
AstraZeneca is the latest Big Pharma company looking to tap into agentic...
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
about 17 hours ago
Kyverna Therapeutics has officially started a rolling submission to the FDA for...
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
about 17 hours ago
Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief...
Charles River debuts AI diagnostic tool to cut down pathology timelines
about 21 hours ago
Charles River is rolling out an artificial intelligence-backed digital pathology platform with...
Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
about 22 hours ago
If any proof was needed that big money is still available for...
Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset
about 23 hours ago
Boehringer Ingelheim has put up 407.5 million euros in biobucks to secure...
AstraZeneca’s $800M bet undermined by immunogenicity in phase 3
1 day ago
Immunogenicity dragged on the efficacy of AstraZeneca’s rare endocrine disorder prospect in...
Roche nabs European approval for second Eli Lilly-partnered Alzheimer’s test
1 day ago
Roche has secured a European CE mark for its second Alzheimer’s test...
Bayer scraps protein therapy for hypertension from phase 1, along with neuropathic pain drug
1 day ago
Bayer has removed a protein therapeutic for hypertension and a treatment for...